menu search

Cytokinetics: biotech that should be on your radar with several catalysts in 2022

Cytokinetics establishes partnership deal with Royalty Pharma for omecamtiv mecarbil and aficamten. Up to $450 million in total is expected for this p...

January 7, 2022, 7:51 pm

Three biotech ipos started trading. here's how the stocks did.

Amylyx Pharmaceuticals raised $190 million, CinCor Pharma collected nearly $194 million, and Vigil Neuroscience came in at $98 million....

January 7, 2022, 1:36 pm

Three biotech ipos started trading. here's how the stocks did.

Amylyx Pharmaceuticals raised $190 million, CinCor Pharma collected nearly $194 million, and Vigil Neuroscience came in at $98 million....

January 7, 2022, 1:36 pm

Three biotech ipos started trading. here's how the stocks did.

Amylyx Pharmaceuticals raised $190 million, CinCor Pharma collected nearly $194 million, and Vigil Neuroscience came in at $98 million....

January 7, 2022, 1:36 pm

Lixte biotechnology stock (lixt): why the price surged today

The stock price of Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) increased by 63.7% in the most recent trading session. This is why it happened....

January 5, 2022, 11:59 pm

Lixte biotechnology stock (lixt): why the price surged today

The stock price of Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) increased by 63.7% in the most recent trading session. This is why it happened....

January 5, 2022, 11:59 pm

Lixte biotechnology stock (lixt): why the price surged today

The stock price of Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) increased by 63.7% in the most recent trading session. This is why it happened....

January 5, 2022, 11:59 pm

Panbela: biotech with updated patent protection and unmet market target indication

Data from phase 1b study using SBP-101 for patients with pancreatic cancer will be shown at the American Society of Clinical Oncology Gastrointestinal...

January 5, 2022, 9:27 pm

Panbela: biotech with updated patent protection and unmet market target indication

Data from phase 1b study using SBP-101 for patients with pancreatic cancer will be shown at the American Society of Clinical Oncology Gastrointestinal...

January 5, 2022, 9:27 pm

Panbela: biotech with updated patent protection and unmet market target indication

Data from phase 1b study using SBP-101 for patients with pancreatic cancer will be shown at the American Society of Clinical Oncology Gastrointestinal...

January 5, 2022, 9:27 pm

Consolidation could come calling for biotech in 2022

Expectations are in place for a brisk pace of consolidation in the biotechnology space this year, and that could benefit an assortment of exchange tra...

January 5, 2022, 1:07 pm

Consolidation could come calling for biotech in 2022

Expectations are in place for a brisk pace of consolidation in the biotechnology space this year, and that could benefit an assortment of exchange tra...

January 5, 2022, 1:07 pm

Consolidation could come calling for biotech in 2022

Expectations are in place for a brisk pace of consolidation in the biotechnology space this year, and that could benefit an assortment of exchange tra...

January 5, 2022, 1:07 pm

The nasdaq biotech index could double in the next few years, says anastasia amoroso

Anastasia Amoroso, iCapital chief investment strategist, joins the 'Halftime Report' to discuss her take on the ...

January 4, 2022, 1:14 pm

The nasdaq biotech index could double in the next few years, says anastasia amoroso

Anastasia Amoroso, iCapital chief investment strategist, joins the 'Halftime Report' to discuss her take on the ...

January 4, 2022, 1:14 pm

The nasdaq biotech index could double in the next few years, says anastasia amoroso

Anastasia Amoroso, iCapital chief investment strategist, joins the 'Halftime Report' to discuss her take on the ...

January 4, 2022, 1:14 pm

Why shares of immunogen jumped 20.3% in december

The biotech company that focuses on oncology drugs released news from a positive clinical trial regardi...

January 3, 2022, 10:36 pm

Why shares of immunogen jumped 20.3% in december

The biotech company that focuses on oncology drugs released news from a positive clinical trial regardi...

January 3, 2022, 10:36 pm

Why shares of immunogen jumped 20.3% in december

The biotech company that focuses on oncology drugs released news from a positive clinical trial regardi...

January 3, 2022, 10:36 pm

Axsome therapeutics: expect victory in 2022

Amid the 2021 biotech Bear market, most bio-stocks are trading at a deep bargain to their intrinsic val...

January 1, 2022, 10:21 am


Search within

Pages Search Results: